Transfusion-associated TT virus infection and its relationship to liver disease

Hepatology

Volumn 30, Issue 1, 1999, Pages 283-288

  Matsumoto, Akihiro ^a   Yeo, Anthony E T ^a   Wai Kuo Shih, J ^a   Tanaka, Eiji ^b   Kiyosawa, Kendo ^b   Alter, Harvey J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DNA VIRUS; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS E; HEPATITIS NON A NON B; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SUPERINFECTION; TORQUE TENO VIRUS; VIREMIA; VIRUS HEPATITIS; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; DISTRICT OF COLUMBIA; DNA VIRUSES; DNA, VIRAL; HEPATITIS ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); POSTOPERATIVE COMPLICATIONS; RED CROSS; RNA, VIRAL; THORACIC SURGICAL PROCEDURES; UNITED STATES;

EID: 0032999224     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300118     Document Type: Article

References (19)

1. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-97.
2. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatology Res 1998;10:1-16.
3. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 1998;12:233-239.
4. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998;352:191-195.
5. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998;352:195-197.
6. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, et al. TT-virus infection in North American blood donors, subjects with fulminant hepatic failure, and cryptogenic cirrhosis. HEPATOLOGY 1998;28:839-842.
7. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1495-1500.
8. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virology 1990;64:1298-1303.
9. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2:121-132.
10. Tsarev SA, Tsareva TS, Emerson SU, Kapikian AZ, Ticehurst J, London W, Purcell RH. ELISA for antibody to hepatitis E virus (HEV) based on complete open reading frame-2 protein expressed in insect Cells: Identification of HEV infection in primates. J Infect Dis 1993;168:369-378.
11. Alter HJ. Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang 1994;67(Suppl 3):19S-24S.
12. Rochling FA, Jones WF, Chau K, DuCharme L, Mimms LT, Moore B, Scheffel J, et al. Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis. HEPATOLOGY 1997;25:478-483.
13. Ferraz ML, Silva AE, Macdonald GA, Tsarev SA, Di Biscelgie AM, Lucey MR. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome. Liver Transpl Surg 1996;2:60-66.
14. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994;89:1836-1839.
15. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;21:362-364.
16. Linnen J, Wages J, Yong Z, Keck Z, Fry KE, Krawczynski KZ, Alter HJ, et al. Molecular Cloning and disease association of hepatitis G virus: a transfusion- transmissible agent. Science 1996;271:506-509.
17. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1:564-569.
18. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, Kim JP. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Eng J Med 1997;336:747-754.
19. Tanaka E, Alter HJ, Nakatsuji Y, Shih JWK, Kim JP, Matsumoto A, Kobayashi M, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996;125:740-743.